- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Alexion Pharmaceuticals Inc+ Add to Watchlist
ALXN:US180.3700 USD 2.7400 1.50%
As of 17:20:00 ET on 02/27/2015.
Company Profile for Alexion Pharmaceuticals Inc (ALXN)
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and Apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.
Alexion Pharmaceuticals Inc
Key Executives for Alexion Pharmaceuticals Inc (ALXN)
|Leonard Bell "Lenny"CEO/Treasurer/Co-Founder||David L HallalChief Operating Officer|
|Vikas SinhaExec VP/CFO||Saqib IslamExec VP/Chief Strategy Ofcr/Portfolio Mgr|
|Clare CarmichaelExec VP/Chief Human Resource Ofcr||John B Moriarty JrExec VP/General Counsel|
|Martin MackayExec VP/Head:Research & Dev||Julie O'NeillExec VP:Global Ops|
|Edward MillerSenior VP/Chief Compliance Ofcr||Elena RidloffExec Dir:Investor Relations|